首页> 外文期刊>The American heart journal >Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
【24h】

Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).

机译:在美国心脏病学会-国家心血管数据注册中心(ACC-NCDR)中,接受经皮冠状动脉介入治疗的急性冠脉综合征患者之间的性别差异。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Although prior studies have demonstrated disparities in the management and outcomes of women with acute coronary syndrome (ACS), there are limited large-scale contemporary data on gender differences in post-intervention outcomes in this population. METHODS: We analyzed patients according to 2 ACS categories, unstable anginaon-ST-elevation myocardial infarction (UA/NSTEMI) and ST-elevation myocardial infarction (STEMI) who had a percutaneous coronary intervention in the ACC-NCDR from January 1, 2004, to March 30, 2006. Of 199,690 patients, 55,691 women presented with UA/NSTEMI, and 12,335 women presented with STEMI. Clinical and angiographic characteristics, procedural and treatment patterns, and in-hospital outcomes were examined. RESULTS: Women presented more often with UA/NSTEMI than men (82% of women vs 77% of men, P < .0001). Despite having greater comorbidities, women in both ACS categories had fewer high risk angiographic features than men. Women were less likely to receive aspirin or glycoprotein IIb/IIIa inhibitors, and were less often discharged on aspirin or statin. For in-hospital mortality, the adjusted odds ratio for men compared to women was similar (odds ratio 0.97, P = .5). Women had higher rates of cardiogenic shock, congestive heart failure, any bleeding, and any vascular complications. Importantly, rates of subacute stent thrombosis were less in women compared to men (0.43% vs 0.57%, P = .0003). CONCLUSIONS: Although women had fewer high-risk angiographic features than men, they continue to have higher rates of in-hospital complications. This suggests the need for gender-tailored techniques to minimize post-intervention complications and maximize application of evidence-based antiplatelet therapies.
机译:背景:尽管先前的研究已经证明了急性冠脉综合征(ACS)妇女在治疗和预后方面存在差异,但有关该人群干预后预后中性别差异的大规模当代数据有限。方法:我们根据2种ACS类别,从1月1日开始对ACC-NCDR进行经皮冠状动脉介入治疗的不稳定型心绞痛/非ST抬高型心肌梗塞(UA / NSTEMI)和ST抬高型心肌梗塞(STEMI)进行了分析。 2004年至2006年3月30日。在199,690名患者中,有55,091名女性出现UA / NSTEMI,12,335名女性出现了STEMI。临床和血管造影特征,程序和治疗方式,以及医院的结果进行了检查。结果:与男性相比,女性患UA / NSTEMI的频率更高(82%的女性对77%的男性,P <.0001)。尽管合并症更大,但两类ACS患者的高危血管造影特征均少于男性。妇女接受阿司匹林或糖蛋白IIb / IIIa抑制剂的可能性较小,而服用阿司匹林或他汀类药物的妇女则较少。对于住院死亡率,男性与女性的调整后优势比相似(优势比为0.97,P = 0.5)。妇女的心源性休克,充血性心力衰竭,任何出血和任何血管并发症的发生率更高。重要的是,女性的亚急性支架血栓形成率低于男性(0.43%比0.57%,P = .0003)。结论:尽管女性的高危血管造影特征少于男性,但她们的院内并发症发生率仍然较高。这表明需要有针对性别的技术,以最大程度地减少干预后并发症并最大程度地应用基于证据的抗血小板治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号